Free press releases distribution network?

Agency / Source: RH Blake, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Prompt Access to Contract Lyophilization and Sterile Pharmaceutical Manufacturing Offered - LyoTechnica, LLC announced today that it has established relationships with multiple parenteral contract manufacturing firms as a means to help speed the development of its clients’ injectable products
Prompt Access to Contract Lyophilization and Sterile Pharmaceutical Manufacturing Offered

 

PRZOOM - /newswire/ - Cleveland, OH, United States, 2010/08/31 - LyoTechnica, LLC announced today that it has established relationships with multiple parenteral contract manufacturing firms as a means to help speed the development of its clients’ injectable products.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

“LyoTechnica supports the activities necessary to file INDs, NDAs or ANDAs,” said Glenn Wickes, Jr., president of LyoTechnica. “With the establishment of our network of parenteral contract manufacturers, we are now able to help our clients by recommending the best fit for their contract manufacturing project, whether it be large or small, requiring lyophilization or not.”

LyoTechnica provides a wide range of contract pharmaceutical development services for liquid or lyophilized aseptic dosage forms, including high potency and cytotoxic products as well as small molecule or biopharmaceutical products. The company can provide fast turnaround for parenteral development projects, and has created a process to develop and complete a typical lyophilization cycle development project in under sixty (60) working days from receipt of client-supplied materials. If sterile stability batches are required, the total project can be completed in under 90 days, according to the company. The company offers development through commercial manufacturing of parenterals at the same site. Lyophilization capacity is up to 19,000 10 ml vials per batch.

LyoTechnica, LLC (lyotechnica.com) also provides regulatory support services, including proven expertise in Electronic Common Technical Development (eCTD) submission services. LyoTechnica’s eCTD affiliate has successfully completed 70 eCTD filings and over 300 Electronic Gateway Submission Filings (ESG).

A complete list of services offered by LyoTechnica, LLC includes process design and development (with container / closure selection, lyophilization development, and lyophilization optimization), global sourcing of APIs, process validation support, design space studies, technology transfer documentation, sourcing of contract parenteral manufacturing, sourcing of qualified contract analytical services, project management, regulatory support services and eCTD submission services.

LyoTechnica, LLC is headquartered at 4747 Beachwood Court, Carlsbad, CA 92008. T: 877-792-3737, F: 760-729-3736, E: info[.]lyotechnica.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: RH Blake, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Prompt Access to Contract Lyophilization and Sterile Pharmaceutical Manufacturing Offered

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Bruce Blake - RHblake.com 
216-595-2400 brb[.]rhblake.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any RH Blake, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From RH Blake, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.

Visit  BizJobs.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today